These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 8413204)

  • 1. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity.
    Cafferkey R; Young PR; McLaughlin MM; Bergsma DJ; Koltin Y; Sathe GM; Faucette L; Eng WK; Johnson RK; Livi GP
    Mol Cell Biol; 1993 Oct; 13(10):6012-23. PubMed ID: 8413204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin.
    Lorenz MC; Heitman J
    J Biol Chem; 1995 Nov; 270(46):27531-7. PubMed ID: 7499212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mammalian protein targeted by G1-arresting rapamycin-receptor complex.
    Brown EJ; Albers MW; Shin TB; Ichikawa K; Keith CT; Lane WS; Schreiber SL
    Nature; 1994 Jun; 369(6483):756-8. PubMed ID: 8008069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast TOR (DRR) proteins: amino-acid sequence alignment and identification of structural motifs.
    Cafferkey R; McLaughlin MM; Young PR; Johnson RK; Livi GP
    Gene; 1994 Apr; 141(1):133-6. PubMed ID: 8163165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense mutations at the FKBP12-rapamycin-binding site of TOR1.
    Freeman K; Livi GP
    Gene; 1996 Jun; 172(1):143-7. PubMed ID: 8654975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tyrosine89 residue of yeast FKBP12 is required for rapamycin binding.
    Koser PL; Eng WK; Bossard MJ; McLaughlin MM; Cafferkey R; Sathe GM; Faucette L; Levy MA; Johnson RK; Bergsma DJ; Livi GP
    Gene; 1993 Jul; 129(2):159-65. PubMed ID: 8325502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.
    Zheng XF; Florentino D; Chen J; Crabtree GR; Schreiber SL
    Cell; 1995 Jul; 82(1):121-30. PubMed ID: 7606777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs.
    Sabatini DM; Erdjument-Bromage H; Lui M; Tempst P; Snyder SH
    Cell; 1994 Jul; 78(1):35-43. PubMed ID: 7518356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue.
    Stan R; McLaughlin MM; Cafferkey R; Johnson RK; Rosenberg M; Livi GP
    J Biol Chem; 1994 Dec; 269(51):32027-30. PubMed ID: 7528205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.
    Sabers CJ; Martin MM; Brunn GJ; Williams JM; Dumont FJ; Wiederrecht G; Abraham RT
    J Biol Chem; 1995 Jan; 270(2):815-22. PubMed ID: 7822316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression.
    Kunz J; Henriquez R; Schneider U; Deuter-Reinhard M; Movva NR; Hall MN
    Cell; 1993 May; 73(3):585-96. PubMed ID: 8387896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast.
    Alarcon CM; Cardenas ME; Heitman J
    Genes Dev; 1996 Feb; 10(3):279-88. PubMed ID: 8595879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein.
    Koltin Y; Faucette L; Bergsma DJ; Levy MA; Cafferkey R; Koser PL; Johnson RK; Livi GP
    Mol Cell Biol; 1991 Mar; 11(3):1718-23. PubMed ID: 1996117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity sequencing of large proteins: partial structure of the rapamycin-FKBP12 target.
    Erdjument-Bromage H; Lui M; Sabatini DM; Snyder SH; Tempst P
    Protein Sci; 1994 Dec; 3(12):2435-46. PubMed ID: 7756997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.
    Alarcon CM; Heitman J; Cardenas ME
    Mol Biol Cell; 1999 Aug; 10(8):2531-46. PubMed ID: 10436010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rapamycin and FKBP12 target (RAFT) displays phosphatidylinositol 4-kinase activity.
    Sabatini DM; Pierchala BA; Barrow RK; Schell MJ; Snyder SH
    J Biol Chem; 1995 Sep; 270(36):20875-8. PubMed ID: 7673106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR.
    Cruz MC; Goldstein AL; Blankenship J; Del Poeta M; Perfect JR; McCusker JH; Bennani YL; Cardenas ME; Heitman J
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3162-70. PubMed ID: 11600372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel FK506- and rapamycin-binding protein (FPR3 gene product) in the yeast Saccharomyces cerevisiae is a proline rotamase localized to the nucleolus.
    Benton BM; Zang JH; Thorner J
    J Cell Biol; 1994 Nov; 127(3):623-39. PubMed ID: 7525596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast.
    Helliwell SB; Wagner P; Kunz J; Deuter-Reinhard M; Henriquez R; Hall MN
    Mol Biol Cell; 1994 Jan; 5(1):105-18. PubMed ID: 8186460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity.
    Cardenas ME; Heitman J
    EMBO J; 1995 Dec; 14(23):5892-907. PubMed ID: 8846782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.